Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.3 (
complex I
)
8,901
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oxidative stress appears to play an important role in degeneration of dopaminergic neurons of the substantia nigra (SN) associated with Parkinson's disease (PD). The SN of early PD patients have dramatically decreased levels of the thiol tripeptide glutathione (GSH). GSH plays multiple roles in the nervous system both as an antioxidant and a redox modulator. We have generated dopaminergic PC12 cell lines in which levels of GSH can be inducibly down-regulated via doxycycline induction of antisense messages against both the heavy and light subunits of gamma-glutamyl-
cysteine synthetase
, the rate-limiting enzyme in glutathione synthesis. Down-regulation of glutamyl-
cysteine synthetase
results in reduction in mitochondrial GSH levels, increased oxidative stress, and decreased mitochondrial function. Interestingly, decreases in mitochondrial activities in GSH-depleted PC12 cells appears to be because of a selective inhibition of
complex I
activity as a result of thiol oxidation. These results suggest that the early observed GSH losses in the SN may be directly responsible for the noted decreases in
complex I
activity and the subsequent mitochondrial dysfunction, which ultimately leads to dopaminergic cell death associated with PD.
...
PMID:Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. 1084 69
Beta-N-Oxalyl amino-L-alanine (L-BOAA), a naturally occurring excitatory amino acid inhibits mitochondrial
complex I
activity in motor cortex and lumbar spinal cord of mice through oxidation of critical thiol groups. Glutaredoxin, a protein disulfide oxido-reductase mediates recovery of
complex I
by regenerating protein thiols utilizing reducing equivalents of glutathione. We have examined the status of gamma-glutamyl
cysteine synthetase
(gamma-GCS), the rate limiting enzyme in glutathione synthesis during recovery of
complex I
function following L-BOAA toxicity. Sustained and maximal up-regulation of gamma-GCS was seen in motor cortex which was associated with regeneration of
complex I
activity. In lumbosacral cord, however, the up-regulation was transient and
complex I
function did not recover. These studies demonstrate the important role of gamma-GCS in mediating the recovery of mitochondrial function following excitotoxic insult and its differential regulation in central nervous system regions.
...
PMID:Gamma-glutamyl cysteine synthetase is up-regulated during recovery of brain mitochondrial complex I following neurotoxic insult in mice. 1296 15